PNC Financial Services Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-68
Closed -$1K 4558
2016
Q2
$1K Sell
68
-2
-3% -$19 ﹤0.01% 4464
2016
Q1
$1K Buy
70
+2
+3% +$15 ﹤0.01% 4457
2015
Q4
$1K Hold
68
﹤0.01% 4408
2015
Q3
$1K Buy
68
+2
+3% +$28 ﹤0.01% 4563
2015
Q2
$1K Buy
66
+21
+47% +$307 ﹤0.01% 4625
2015
Q1
$0 Sell
45
-117
-72% -$1.26K ﹤0.01% 4827
2014
Q4
$1K Buy
162
+51
+46% +$439 ﹤0.01% 4091
2014
Q3
$1K Buy
+111
New +$2.19K ﹤0.01% 3928

Other funds holding TBRA

PNC Financial Services Group's TBRA Position: Q3 2016 in Review

PNC Financial Services Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2016, closing a stake of 68 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in TBRA in Q3 2014 and held it in 8 quarters. The position peaked at $1K in Q2 2016. 68 funds tracked by Wall St. Rank hold TBRA as of Q3 2016.

  • PNC Financial Services Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • PNC Financial Services Group sold 68 Tobira Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $1K.
  • PNC Financial Services Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2014 and held it in 8 quarters.
  • PNC Financial Services Group's Tobira Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2016.
  • 68 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2016.

Based on PNC Financial Services Group's 13F filing for Q3 2016, filed 4 Nov 2016.